State of the Art of Lipid Apheresis |
| |
Authors: | Thomas Bosch |
| |
Institution: | Klinikum Grosshadern, University of Munich, Munich, Germany |
| |
Abstract: | Abstract: Currently, 5 different lipid apheresis procedures are available for routine clinical treatment of hy–percholesterolemic patients. Unselective plasma exchange is a technically simple extracorporeal circuit, but albumin substitution fluid must be used and there is no high–density lipoprotein (HDL) recovery. Semiselective double filtration with improved size selectivity because of a small–pore secondary filter combines good elimination of low–density lipoprotein (LDL), lipoprotein (a) (Lpa]), and fibrinogen with adequate HDL recovery; modifications such as thermofiltration, predilution/backflush, or pulsatile flow have been proposed for the improvement of this system. Three highly selective procedures are basedon immunologic or electrostatic interactions: immunoad–sorption using anti–low–density lipoprotein (LDL) antibodies, chemoadsorption onto dextran sulfate, and hep–arin–induced LDL precipitation (HELP) apheresis. The features of each system are discussed critically. Lastly, two new developments, Lp(a) immunoadsorption and LDL hemoperfusion using a polyacrylate LDL adsorber compatible with whole blood, are described |
| |
Keywords: | Lipid apheresis Plasma exchange Double filtration Dextran sulfate Immunoadsorption Heparin-induced LDL precipitation Low-density lipoprotein cholesterol Lipoprotein (a)–LDL hemoperfusion |
|
|